Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2010, Article ID 537531, 10 pages
http://dx.doi.org/10.1155/2010/537531
Research Article

Clinicopathologic Significance of HIF-1 , CXCR4, and VEGF Expression in Colon Cancer

1Department of Surgery, The First People Hospital of Changzhou and The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, China
2Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Shanghai Jiao Tong University School of Medicine, Chinese Academy of Sciences, Shanghai 200025, China
3Department of Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China

Received 28 June 2010; Revised 26 August 2010; Accepted 15 September 2010

Academic Editor: Silvano Sozzani

Copyright © 2010 Yugang Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Rougier, T. Andre, Y. Panis, P. Colin, N. Stremsdoerfer, and P. Laurent-Puig, “Colon cancer,” Gastroenterologie Clinique et Biologique, vol. 30, no. 2, pp. S2–S24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Mano and F. Duhoux, “Colon cancer: update on adjuvant therapy,” Clinical Colorectal Cancer, vol. 7, no. 3, pp. 178–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: A Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. B. Rankin and A. J. Giaccia, “The role of hypoxia-inducible factors in tumorigenesis,” Cell Death and Differentiation, vol. 15, no. 4, pp. 678–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Poon, A. L. Harris, and M. Ashcroft, “Targeting the hypoxia-inducible factor (HIF) pathway in cancer,” Expert Reviews in Molecular Medicine, vol. 11, article e26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Y. Koh, T. R. Spivak-Kroizman, and G. Powis, “HIF-1alpha and cancer therapy,” Recent Results in Cancer Research, vol. 180, pp. 15–34, 2010. View at Publisher · View at Google Scholar
  7. R. H. Wenger, D. P. Stiehl, and G. Camenisch, “Integration of oxygen signaling at the consensus HRE,” Science's STKE, vol. 2005, no. 306, article re12, 2005. View at Google Scholar · View at Scopus
  8. T. Ishikawa, K.-I. Nakashiro, S. K. Klosek et al., “Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma,” Oncology Reports, vol. 21, no. 3, pp. 707–712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Burger and T. J. Kipps, “CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment,” Blood, vol. 107, no. 5, pp. 1761–1767, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou, “Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis,” American Journal of Physiology, vol. 292, no. 3, pp. C987–C995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Arya, H. Ahmed, N. Silhi, M. Williamson, and H. R. H. Patel, “Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration,” Tumor Biology, vol. 28, no. 3, pp. 123–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan et al., “Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1,” Nature Medicine, vol. 10, no. 8, pp. 858–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. J. Nieves, P. A. D'Amore, and B. A. Bryan, “The function of vascular endothelial growth factor,” BioFactors, vol. 35, no. 4, pp. 332–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Hicklin and L. M. Ellis, “Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis,” Journal of Clinical Oncology, vol. 23, no. 5, pp. 1011–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Chen, A. Endler, and F. Shibasaki, “Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors,” Experimental and Molecular Medicine, vol. 41, no. 12, pp. 849–857, 2009. View at Publisher · View at Google Scholar
  16. H. F. Dvorak, “Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy,” Journal of Clinical Oncology, vol. 20, no. 21, pp. 4368–4380, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Hao, C. Zhang, Y. Qiu et al., “Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer,” Cancer Letters, vol. 253, no. 1, pp. 34–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Q.-T. Le and A. J. Giaccia, “HIF-α, a gender independent transcription factor,” Clinical Cancer Research, vol. 9, no. 7, pp. 2391–2393, 2003. View at Google Scholar · View at Scopus
  19. P. J. Kallio, W. J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger, “Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway,” Journal of Biological Chemistry, vol. 274, no. 10, pp. 6519–6525, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. C. W. Pugh and P. J. Ratcliffe, “The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis,” Seminars in Cancer Biology, vol. 13, no. 1, pp. 83–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. V. E. Belozerov and E. G. Van Meir, “Hypoxia inducible factor-1: a novel target for cancer therapy,” Anti-Cancer Drugs, vol. 16, no. 9, pp. 901–909, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Simiantonaki, M. Taxeidis, C. Jayasinghe, U. Kurzik-Dumke, and C. J. Kirkpatrick, “Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression,” BMC Cancer, vol. 8, article 320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Evans, R. C. Russell, O. Roche et al., “VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail,” Molecular and Cellular Biology, vol. 27, no. 1, pp. 157–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. T. Erler and A. J. Giaccia, “Lysyl oxidase mediates hypoxic control of metastasis,” Cancer Research, vol. 66, no. 21, pp. 10238–10241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C.-C. Chang, M.-T. Lin, B.-R. Lin et al., “Effect of connective tissue growth factor on hypoxia-inducible factor 1α degradation and tumor angiogenesis,” Journal of the National Cancer Institute, vol. 98, no. 14, pp. 984–995, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. L. D. Sprague, H. Tomaso, K. Mengele et al., “Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells,” Oncology Reports, vol. 17, no. 5, pp. 1259–1268, 2007. View at Google Scholar · View at Scopus
  27. S. Gelmini, M. Mangoni, M. Serio, P. Romagnani, and E. Lazzeri, “The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis,” Journal of Endocrinological Investigation, vol. 31, no. 9, pp. 809–819, 2008. View at Google Scholar · View at Scopus
  28. X. Sun, L. Wei, Q. Chen, and R. M. Terek, “CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression,” Molecular Cancer, vol. 9, article 17, 2010. View at Publisher · View at Google Scholar
  29. C. C. Schimanski, S. Schwald, N. Simiantonaki et al., “Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer,” Clinical Cancer Research, vol. 11, no. 5, pp. 1743–1750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Zagzag, Y. Lukyanov, L. Lan et al., “Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion,” Laboratory Investigation, vol. 86, no. 12, pp. 1221–1232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Wang, C. Li, Y. Chen et al., “Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1α activation,” Biochemical and Biophysical Research Communications, vol. 371, no. 2, pp. 283–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Kaur, F. W. Khwaja, E. A. Severson, S. L. Matheny, D. J. Brat, and E. G. Van Meir, “Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis,” Neuro-Oncology, vol. 7, no. 2, pp. 134–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. K. M. Harms, L. Li, and L. A. Cunningham, “Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling,” PLoS One, vol. 5, no. 3, article e9767, 2010. View at Google Scholar
  34. Z. Arany, S.-Y. Foo, Y. Ma et al., “HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α,” Nature, vol. 451, no. 7181, pp. 1008–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Hua, Q. Lv, W. Ye et al., “Mirna-directed regulation of VEGF and other angiogenic under hypoxia,” PLoS ONE, vol. 1, no. 1, article e116, 2006. View at Publisher · View at Google Scholar
  36. B. K. McColl, S. A. Stacker, and M. G. Achen, “Molecular regulation of the VEGF family—inducers of angiogenesis and lymphangiogenesis,” APMIS, vol. 112, no. 7-8, pp. 463–480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Mizukami, J. Li, X. Zhang, M. A. Zimmer, O. Iliopoulos, and D. C. Chung, “Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer,” Cancer Research, vol. 64, no. 5, pp. 1765–1772, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Neuhaus, S. Stier, G. Totzke et al., “Stromal cell-derived factor 1α (SDF-1α) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation,” Cell Proliferation, vol. 36, no. 2, pp. 75–86, 2003. View at Publisher · View at Google Scholar
  39. X. Hong, F. Jiang, S. N. Kalkanis et al., “SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion,” Cancer Letters, vol. 236, no. 1, pp. 39–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Galbán, Y. Kuwano, R. Pullmann Jr. et al., “RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1α,” Molecular and Cellular Biology, vol. 28, no. 1, pp. 93–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Galbán and M. Gorospe, “Factors interacting with HIF-1α mRNA: novel therapeutic targets,” Current Pharmaceutical Design, vol. 15, no. 33, pp. 3853–3860, 2009. View at Publisher · View at Google Scholar · View at Scopus